Vioxx

   
Google
 
Web NewDrugInformation.com

Vioxx


Drug - Vioxx
The trade name of the product as shown on the labeling.

Dosage - SUSPENSION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Rofecoxib
Multiple ingredients are in alphabetical order.

Strength - 25MG/5ML
The potency of the active ingredient(s), Rofecoxib. May repeat for multiple part products.

Applicant - MERCK
The firm name holding legal responsibility for Vioxx. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021052
The FDA assigned number to Vioxx. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Vioxx. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 20, 1999
The date Vioxx was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Vioxx. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Vioxx is in. Format is RX, OTC, DISCN.

Applicant Full Name - Merck Research Laboratories Div Merck Co Inc
The full name of the firm holding legal responsibility for the new application of Vioxx.

Vioxx